Learn about CYTK with our data and independent analysis including price, star rating, valuation, dividends, and financials. Start a 14-day free trial to Morningstar Premium to unlock our take on CYTK. QuantConnect-US-Equities-Asset-List.xlsx | Corporate Law PDF Find the latest Cytokinetics, Incorporated (CYTK) stock quote, history, news and other vital information to help you with your stock trading and investing. CYTK | Complete Cytokinetics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. A high-level overview of Cytokinetics, Incorporated (CYTK) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and
3312, cytk. 3313, cyto. 3314, cytr. 3315, cytx. 3316, cz. 3317, cza. 3318, czc. 3319 , czfc. 3320, czg 9905, opsi. 9906, opsw 12631, stok. 12632, ston.
Plus, the 36-month beta value for CYTK is at 1.38. Opinions of the stock are interesting as 8 analysts out of 8 who provided ratings for Cytokinetics Incorporated declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.” Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on October 30, 2020 it granted stock options to purchase an aggregate of 2,850 shares of common stock to Cuong Nguyen, a new employee whose This is a Bullish indicator signaling CYTK's price could rise from here. Traders may explore going long the stock or buying call options. Tickeron A.I. dvisor identified 44 similar cases where CYTK's MACD histogram became positive, and 42 of them led to successful outcomes. Odds of Success: 90%. Big movements in Cytokinetics stock price on Friday moving 12.13% between high and low (Updated on November 13, 2020) Sell candidate since 2020-11-13 PDF The Cytokinetics stock price fell by -5.06% on the last day (Friday, 13th Nov 2020) from $17.40 to $16.52. During the day the stock fluctuated 12.13% from a day low at $16.00 to a day high of
Find the latest on option chains for OPKO Health, Inc. Common Stock (OPK) at Nasdaq.com.
This is a Bullish indicator signaling CYTK's price could rise from here. Traders may explore going long the stock or buying call options. Tickeron A.I. dvisor identified 44 similar cases where CYTK's MACD histogram became positive, and 42 of them led to successful outcomes. Odds of Success: 90%. Big movements in Cytokinetics stock price on Friday moving 12.13% between high and low (Updated on November 13, 2020) Sell candidate since 2020-11-13 PDF The Cytokinetics stock price fell by -5.06% on the last day (Friday, 13th Nov 2020) from $17.40 to $16.52. During the day the stock fluctuated 12.13% from a day low at $16.00 to a day high of Cytokinetics (CYTK) in Focus: Stock Moves 5.7% Higher Cytokinetics (CYTK) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes. Zacks Equity Research 10/05/2020 02:48 AM ET Learn about CYTK with our data and independent analysis including price, star rating, valuation, dividends, and financials. Start a 14-day free trial to Morningstar Premium to unlock our take on CYTK.
OPK: Get the latest Opko Health stock price and detailed information including OPK news, historical charts and realtime prices.
Big movements in Cytokinetics stock price on Friday moving 12.13% between high and low (Updated on November 13, 2020) Sell candidate since 2020-11-13 PDF The Cytokinetics stock price fell by -5.06% on the last day (Friday, 13th Nov 2020) from $17.40 to $16.52. During the day the stock fluctuated 12.13% from a day low at $16.00 to a day high of Cytokinetics (CYTK) in Focus: Stock Moves 5.7% Higher Cytokinetics (CYTK) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes. Zacks Equity Research 10/05/2020 02:48 AM ET
Products. 100G. QSFP28. Optink Technology 100G QSFP28 series optical module products include LR4, LR4-RX, ER4, CWDM4, PSM4, SR4 and other series. This series of products adopts LC or MPO optical …
Plus, the 36-month beta value for CYTK is at 1.38. Opinions of the stock are interesting as 8 analysts out of 8 who provided ratings for Cytokinetics Incorporated declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.” Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on October 30, 2020 it granted stock options to purchase an aggregate of 2,850 shares of common stock to Cuong Nguyen, a new employee whose This is a Bullish indicator signaling CYTK's price could rise from here. Traders may explore going long the stock or buying call options. Tickeron A.I. dvisor identified 44 similar cases where CYTK's MACD histogram became positive, and 42 of them led to successful outcomes. Odds of Success: 90%. Big movements in Cytokinetics stock price on Friday moving 12.13% between high and low (Updated on November 13, 2020) Sell candidate since 2020-11-13 PDF The Cytokinetics stock price fell by -5.06% on the last day (Friday, 13th Nov 2020) from $17.40 to $16.52. During the day the stock fluctuated 12.13% from a day low at $16.00 to a day high of Cytokinetics (CYTK) in Focus: Stock Moves 5.7% Higher Cytokinetics (CYTK) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes. Zacks Equity Research 10/05/2020 02:48 AM ET